The UK life sciences industry is a significant asset. The King’s Fund and Gilead Sciences examined how the NHS can collaborate with such partners by exploring 4 case studies – one aiming to eliminate hepatitis C among people in NHS Addictions Provider Alliance drug and alcohol services. They identified 3 broad domains: purpose, people and process.